Applying Novel Strategies to the Treatment of Advanced Renal Cell Carcinoma

Share

Supporters

Supported by educational grants from Exelixis, Inc., and Merck Sharp & Dohme LLC.

Exelixis, Inc.

Merck Sharp & Dohme, LLC